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Summary. Despite the immediate event, such as 
cerebral trauma, cardiac arrest, or stroke that may result 
in neuronal or vascular injury, specific cellular signal 
transduction pathways in the central nervous system 
ultirnately influence the extent of cellular injury. Yet, it 
is a cascade of mechanisms, rather than a single cellular 
pathway, which determine cellular survival during toxic 
insults. Although neuronal injury associated with several 
disease entities, such as Alzheimer's disease, Parkinson's 
disease, and cerebrovascular disease was initially 
believed to be irreversible, it has become increasingly 
evident that either acute or chronic modulation of the 
cellular and molecular environment within the brain can 
prevent or even reverse cellular injury. In order to 
develop rational, efficacious, and safe therapy against 
neurodegenerative disorders, it becomes vital to 
elucidate the cellular and molecular mechanisms that 
control neuronai and vascular injury. These include the 
pathways of free radical injury, the independent 
mechanisms of programmed cell death, and the 
downstream signal transduction pathways of 
endonuclease activation, intracellular pH, cysteine 
proteases, the cell cycle, and tyrosine phosphatase 
activity. Employing the knowledge gained from 
investigations into these pathways will hopefully further 
efforts to successfully develop effective treatments 
against central nervous system disorders. 
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Anoxic injury and free radical induction of neuronal 
and vascular cell degeneration 
One of the initial inciting events that may precipitate 
both neuronal and vascular injury is the loss of oxygen 
to the cellular environment. The absence of oxygen to 
neuronal or vascular cells is not an "al1 or none" process, 
but may occur in various degrees with each leve1 of 
oxygen loss capable of precipitating cellular injury. The 
individual levels of oxygen loss can be described as 
anoxic anoxia, anemic anoxia, and ischemia. Anoxic 
anoxia consists of reduced arteria1 oxygen content and 
tension. This may be secondary to decreased oxygen in 
the environment or an inability for oxygen to enter the 
circulatory system such as during loss of cardiac 
function. Anemic anoxia consists of low oxygen content 
in the blood secondary to decreased hemoglobin content. 
Ischemic anoxia describes a state of insufficient cerebral 
blood flow. Such decreased flow states may result from 
cardiopulmonary collapse or during increased cerebral 
vascular resistance, such as in migraine or stroke. 
Interestingly, a "window of opportunity" for either 
the prevention or reversal of ischemic disease to the 
nervous system exists. For example, the therapeutic 
window for the treatment of cerebral ischemia is narrow, 
usually less than six hours, and requires the rapid 
reversal of toxic cellular events (Maiese et al., 1993b; 
Yang et al., 2000). Although the core of an ischemic 
insult suffers from loss of cerebral blood flow and 
metabolism, the region surrounding the ischemic core is 
characterized by decreased blood flow and secluded 
regions of hypermetabolism (Back, 1998). 
Pharmacological manipulation with agents such as 3- 
nitropropionic acid (Brambrink et al., 2000), 
nicotinamide (Lin et al., 2000), and irnidazole receptor 
binding agents (Maiese et al., 1992) have been shown to 
reduce the extent of ischemia within the penumbra1 
zone. In addition, muscarinic agonists have been 
demonstrated to possibly influence neuronal plasticity 
(Maiese et al., 1994a). 
Yet, subsequent neuronal and vascular degeneration 
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disturbed cellular function and eventually precipitate 
disorders such as atherogenesis (Dimmeler et al., 1997; 
Galle et al., 1999). 
PCD is considered to be an active, directed process 
that can rapidly lead to the destruction of a cell. In 
contrast to necrosis, PCD is characterized by the 
preservation of membrane integrity and interna1 
organellae structure, chromatin condensation with 
nuclear fragmentation, and the budding of cellular 
fragrnents known as "apoptotic bodies". In most cellular 
systems, the end result of PCD is termed apoptosis (Kerr 
et al., 1972). In some cases, PCD requires de novo gene 
expression with subsequent protein synthesis (Ellis et al., 
1991). The detailed understanding of the cellular 
mechanisms that modulate PCD may provide the basis 
for novel therapeutic strategies to prevent or reverse 
neuronal loss. 
Neurona1 and vascular PCD is believed to proceed 
through two dynamic, but distinct pathways that involve 
both DNA fragmentation and the loss of membrane 
asymmetry with the exposure of membrane 
phosphatidylserine (PS) residues (Vincent and Maiese, 
1999a; Lin et al., 2000; Maiese and Vincent, 2000b). 
These processes are considered to be functionally 
independent determinants of PCD. The internucleosomal 
cleavage of genomic DNA into fragments may be a late 
event during PCD and ultimately commit a cell to its 
demise (Fig. 2). In contrast, the redistribution of 
membrane PS residues can be an early event during PCD 
(Martin et al., 1995; Rimon et al., 1997) that usually 
precedes DNA fragmentation and may serve to later 
"tag" injured cells for phagocytosis (Savill, 1997). 
One of the most central issues surrounding PCD 
focuses on whether this process, once initiated, is 
committed in nature to lead to cellular death or is 
reversible to the extent of preventing further neuronal 
injury. In order to assess the reversiblity of PCD, assays 
that could monitor the induction of PCD in living cells 
required development. Current techniques employed to 
assess PCD, such as terminal deoxyUTP nick end 
labelling (TUNEL) or transmission electron microscopy, 
are useful to identify the extent of PCD induction in 
fixed tissue (Vincent et al., 1997; Fiorucci et al., 1999). 
Yet, these procedures lack the ability to assess dynamic 
changes in PCD in individual cells. As an alternative, a 
recently developed technique can now monitor the 
induction and change in PCD in individual living cells 
over a period of time. The method employs the 
reversible labelling of annexin V to exposed PS residues 
of cells undergoing PCD (Vincent and Maiese, 1999a; 
Maiese and Vincent, 2000b). By exploiting the 
dependence of annexin V on extra-cellular calcium to 
bind to exposed membrane PS residues, the technique 
can reversibly label individual cells. During the 
induction of PCD, such as following NO exposure, 
progressive externalization of membrane PS residues 
occurs that is independent of the loss of cellular 
membrane integrity (Fig. 3). 
Studies employing cytoprotectants, such as the 
application of either trophic factors (Kiprianova et al., 
1999), metabotropic glutamate receptor agonists 
(Vincent et al., 1999a; Maiese et al., 2000b; Vincent and 
Maiese, 2000), benzothiazole compounds (Maiese and 
Vincent, 2000a,b), Bcl-2 expression (Fabisiak et al., 
1997), or nicotinamide (Ayoub et al., 1999; Lin et al., 
2000; Mokudai et al., 2000) have shed some light in 
support of the concept of reversible injury during PCD. 
For example, since cytosolic and nuclear changes 
associated with PCD are evident within the first hour of 
NO exposure (Vincent et al., 1997; Adayev et al., 1998), 
the signal transduction mechanisms of the metabotropic 
glutamate system may reverse early steps in PCD. It is 
conceivable that these cytoprotective agents maintain 
membrane PS asymmetry through the modulation of 
Rg. 2. NO exposure leads to the induction of DNA fragmentation in cerebral vascular endothelial cells. Representative fields of ECs illustrate the effect 
of NO on DNA fragmentation in EC cuitures. DNA fragmentation was determined by TUNEL staining 24 hr following NO exposure (NOC-9, 1000 pM). 
In contrast to untreated control cultures (A), a significant increase in the number of TUNEL-positive ECs (brown stained cells) is seen in cultures treated 
with the NO donor (B). x 200 
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random "flip-flop" membrane phospholipids (Bratton et 
al., 1997). Alternatively, they may maintain cellular 
energy metabolism since exposure of membrane PS 
residues on the membrane surface is an active process 
facilitated by an ATP-dependent membrane translocase 
(Verhoven et al., 1999). 
In light of the independence of PS externalization 
and DNA degradation during PCD, one of the critica1 
issues concerns the biological role of PS externalization. 
In other systems, PS externalization can signal for the 
phagocytosis of cells (Rimon et al., 1997; Savill, 1997). 
In the nervous system, cells expressing extemalized PS 
also may be removed by microglia (Savill, 1997). An 
additional role of PS externalization in vascular cell 
systems is the activation of coagulation cascades. The 
externalization of PS in platelets or ECs can promote the 
formation of a procoagulant surface (Bombeli et al., 
1997). Therefore, in addition to the prevention of the 
phagocytosis of neurons, the ability to prevent and 
reverse PS externalization may avert vascular injury in 
disorders such as stroke and Alzheimer's disease. Thus, 
the ability of a specific cytoprotectant to prevent PS 
externalization may provide greater overall cellular 
protection through both maintenance of genomic DNA 
integrity and the prevention of PS externalization that 
can signal phagocytosis. 
Cellular mechanisms of neuronal and vascular 
programmed cell death 
lnduction of endonuclease activation 
The orderly cleavage of genomic DNA into 
nucleosomal or oligonucleosomal lengths is considered 
to be one of the hallmarks of PCD. Exclusive of the 
nervous system, a variety of enzymes responsible for 
chromatin degradation have been differentiated based on 
their ionic sensitivities to zinc (Walker et al., 1994) and 
magnesium (Sun and Cohen, 1994). Interest also has 
focused on the calcium/magnesium-dependent 
endonucleases such as DNase 1 (Madaio et al., 1996), the 
acidic, cation independent endonuclease (DNase 11) 
(Torriglia et al., 1995), cyclophilins (Montague et al., 
1997), and the 97 kDa magnesium-dependent 
endonuclease (Pandey et al., 1997). Yet, no clear 
consensus exists concerning the ability of any one or 
combination of endonucleases to invoke PCD, especially 
in the central nervous system. 
Through the use of gel electrophoresis, electron 
microscopy, and cytochemical staining, active DNA 
degradation is believed to be a significant component of 
cellular PCD following free radical injury with NO 
toxicity (Fehsel et al., 1995; Maiese, 1998; Ishikawa et 
al., 1999). These studies have been extended to 
demonstrate that modulation of endonuclease activity 
directly influences neuronal survival in the presence of 
NO (Vincent and Maiese, 1999b; Vincent et al.,. 1999b). 
Employing in vitro assays of endonuclease activity, three 
endonucleases have been characterized, each with 
specific pH and divalent cation requirements, that are 
necessary for the induction of NO induced PCD. In 
addition, the activities of these endonucleases are 
physiologically dependent upon the intracellular pH 
changes induced by NO. 
Three separate endonuclease activities are present 
during NO induced PCD. They are a constitutive acidic 
cation-independent endonuclease, a constitutive 
calcium/magnesium-dependent endonuclease, and an 
inducible magnesium dependent endonuclease (Vincent 
and Maiese, 1999b). In non-neurona1 systems, 
endonucleases similar to the constitutive acidic cation- 
independent endonuclease and the constitutive 
Flg. 3. NO leads to the development of rnernbrane PS residue exposure in cerebral vascular endothelial cells. A representative field of Ees illustrates 
the effect of NO on the exposure of membrane PS residues in EC cultures. Annexin V staining was petformed 12 hours following NO exposure (NOC 
9, 1OOOpM). The ECs were imaged by fluorescent light in untreated control cultures (A) and in cultures exposed to NO (B) using 490 nm excitation and 
585 nm emission wavelengths to locate the annexin V-phycoerythrin label. NO-induced membrane PS exposure is visualized on the membrane surface 
of the ECs in panel B. x 200 
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calcium/magnesium-dependent endonuclease have been 
proposed as potentially having a role in PCD (Barry and 
Eastman, 1993; Montague et al., 1997; Pandey et al., 
1997). 
The inducible magnesium-dependent endonuclease 
rnay be unique for the nervous system (Vincent and 
Maiese, 1999b). Although the physiologic characteristics 
of the magnesium dependent endonuclease, such as a pH 
range of 7.4-8.0, a dependence on magnesium, and a 
molecular weight of 95-108 kDa, are consistent with a 
recently described constitutive 97 kDa endonuclease in 
non-neurona1 tissues, the endonuclease in the nervous 
system is inducible during NO exposure rather than 
constitutive. Yet, it is also conceivable that the recently 
identified inducible magnesium-dependent endonuclease 
is a cleavage product of the constitutive calciuml 
magnesium-dependent endonuclease. This has not been 
previously reported, but rnay clarify the discrepancy of 
whether multiple endonucleases can function in concert 
or require the existence of a multi-functional 
endonuclease to cleave DNA in a particular cellular 
system. For example, some investigators have described 
sequential DNA degradation by a calcium/magnesium- 
dependent endonuclease that rnay become cleaved to 
yield a magnesium-dependent endonuclease (Cain et al., 
1995). 
The generation of free radicals, such as during the 
exposure of NO, has been suggested to be sufficient to 
directly result in the degradation of DNA (Wink et al., 
1991). Yet, in some systems, DNA degradation 
following NO exposure required a downstream mediator, 
such as endonuclease activation (Vincent and Maiese, 
1999b; Vincent et al., 1999a). As a result, the greatest 
potential for the treatment of neuronal or vascular 
degeneration appears to lie with the investigation of the 
subsequent cellular and molecular mechanisms that 
determine cellular survival. In this respect, modulation 
of the activity of either the constitutive or inducible pH 
dependent endonucleases rnay prevent or reverse cellular 
injury. Elucidating the role of specific endonucleases in 
cellular PCD will hopefully provide further insight into 
the molecular mechanisms that mediate free radical 
neuronal injury. 
Free radical modulation of intracellular pH 
As described during the induction of PCD, multiple 
endonucleases rnay be responsible for the destruction of 
a particular cell's genome (Torriglia et al., 1995; Madaio 
et al., 1996; Pandey et al., 1997; Vincent and Maiese, 
1999b). Yet, what appears to be physiologically relevant 
for each of the endonuclease activities is the intracellular 
pH during PCD (Meisenholder et al., 1996). Present 
work has suggested that intracellular acidification rnay 
be both necessary and sufficient for the induction of 
PCD during free radical injury and identifies the 
modulation of intracellular pH as a possible therapeutic 
target against neuronal degeneration (Vincent and 
Maiese, 1999b; Vincent et al., 1999a,b). 
Reactive oxygen species have been postulated as a 
potential mechanism for the induction of acidosis- 
induced cellular toxicity (Shen et al., 1995). Although 
NO toxicity can invoke multiple mechanisms to induce 
cellular degeneration, such as protein kinase C or protein 
kinase A activity (Maiese et al., 1993b; Maiese and 
Boccone, 1995), cellular calcium release (Maiese et al., 
1994b; Clementi et al., 1996), and endonuclease 
activation (Vincent and Maiese, 1999b), NO injury is 
also clearly linked to intracellular acidification (Ito et al., 
1997; Vincent et al., 1999b; Maiese et al., 2000b). NO 
employs rapid but transient intracellular acidification as 
a downstream mediator of neuronal degeneration. 
Prevention of NO induced intracellular acidification 
markedly, but not completely, improves neuronal 
survival, illustrating the pathophysiological contribution 
of NO induced intracellular acidification during neuronal 
degeneration (Vincent et al., 1999b). In addition, cellular 
injury and PCD during either NO or intracellular 
acidification are partially dependent upon endonuclease 
activation. Enhanced activity of the acidic-dependent 
endonuclease is believed to contribute to genomic DNA 
destruction during the abrupt intracellular acidification 
by NO. To a similar degree, the calcium/magnesium- 
dependent and the magnesium-dependent endonucleases 
rnay participate in cellular injury during the secondary 
biphasic intracellular alkalinization induced by NO 
(Vincent and Maiese, 1999b; Vincent et al., 1999a,b). 
Thus, free radical NO toxicity, at least in part, is 
dependent upon the initial acidification of the neuronal 
intracellular environment. 
Cysteine proteases mediate genomic DNA degradation 
and membrane PS exposure 
Some of the pathways that are responsible for the 
generation of genomic DNA degradation and membrane 
PS exposure during neuronal PCD result from the 
activation of a farnily of cysteine proteases. The cysteine 
proteases (caspases) are mammalian homologues of the 
C. elegans cell death (CED) genes (Ellis and Horvitz, 
1986). Each of the aspartate-specific cysteine proteases 
is synthesized as a proenzyme that is proteolytically 
cleaved to subunits that form catalytically active 
heterodimers during development or injury (Martin and 
Green, 1995). Investigations with the cysteine proteases 
caspase 1 and caspase 3 have been implicated to lead to 
the induction of neuronal PCD (Du et al., 1997; Krohn et 
al., 1998; Maiese and Vincent, 1999). Caspase 1-like 
proteases rnay promote DNA degradation through the 
activation of other proteins, such as protein kinase C 
(Emoto et al., 1995) and caspase 3 (Enari et al., 1996). In 
some cellular systems, caspase 3-like proteases can 
cleave fodrin and foca1 adhesion kinase to induce 
membrane PS residue exposure during PCD (Levkau et 
al., 1998). In addition, the caspase 3-like proteases have 
been directly linked to the development of DNA 
fragmentation (Enari et al., 1998). 
The subsequent downstream pathways that mediate 
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NO-induced PCD appear to be closely linked to the 
modulation of cysteine protease activity, but continue to 
require further investigation. Generation of NO in 
neurons can elicit cysteine protease activity and directly 
stimulate caspase 1 and caspase 3-like activities (Brune 
et al., 1999; Maiese et al., 2000b) (Fig. 4). This signal 
transduction system of cysteine protease activation by 
NO also appears to be maintained in ECs (Maiese et al., 
2000a). In addition, activation of the metabotropic 
glutamate system mediates protection against PCD in 
neurons and in ECs through the direct inhibition of both 
caspase 1 and caspase 3-like activities (Maiese and 
Vincent, 1999; Maiese et al., 2000b). 
Further work has examined the ability of caspase 1- 
like and caspase 3-like activities to directly modulate 
genomic DNA degradation following NO exposure. 
Exposure to NO can directly lead to the induction of 
both caspase 1-like and caspase 3-like activities over a 
period of twenty-four hours (Brown and Borutaite, 1999; 
Maiese and Vincent, 1999; Maiese et al., 2000b; Yabuki 
et al., 2000; Yamaguchi et al., 2000). This leve1 of 
activity is sustained over a 24 hour period of time. In 
addition, NO-induced PCD is dependent, at least in part, 
upon the generation of cysteine protease activity since 
inhibition of either caspase 1 or caspase 3 activity can 
prevent either neuronal or vascular EC injury. It is 
believed that caspase 1 and caspase 3 rnay sequentially 
activate each other, since the individual inhibition of 
Caspase 1 
Control 
NO 
Flg. 4. NO enhances caspase 1 and caspase 3-like activities in 
neurons. To investigate whether NO-induced neuronal injury is linked to 
the generation of caspase activity, caspase 1 and caspase 3-like 
activities were determined by rneasuring the cleavage of colorimetric 
substrates following NO exposure. Caspase 1-like activity was 
determined by measuring the cleavage of Ac-WAD-pNA at 24 hrs 
following NO exposure (NOC-9, 300 pM). NO exposure significantly 
increased caspase 1-like activity 24 hrs following NO treatment 
compared to untreated control cultures. Caspase 3-like activity was 
deterrnined by measuring the cleavage of Ac-DEVD-pNA at 24 hrs 
following NO exposure (NOC-9, 300 pM). NO exposure significantly 
increased caspase 3-like actiiity 24 hrs aíter NO exposure cornpared to 
untreated control cultures. Data for caspase 1 and caspase 3-like 
activities represent the mean and SE. 
either cysteine protease can prevent genomic DNA 
degradation to a similar degree (Lin et al., 2000; Maiese 
et al., 2000b). A cascade of caspase activation has been 
demonstrated for various members of the caspase family 
(Marks and Berg, 1999). In particular, caspase 1-like 
activity rnay lead directly or indirectly to the induction 
of caspase 3-like activity (Enari et al., 1996). 
The degradation of genomic DNA also rnay be 
directly associated with the individual induction of 
caspase 3-like protease activity. For example, caspase 3- 
like proteases cleave a constitutive endonuclease 
inhibitor that can degrade genomic DNA (Enari et al., 
1998). Caspase 3-like proteases also cleave poly(ADP- 
ribose) polymerase (PARP). PARP has been shown to be 
required for DNA repair and functions by attaching 
poly(ADP-ribose) at DNA strand breaks (Cristovao and 
Rueff, 1996). A significant decrease in intact PARP 
following exposure to NO has been recently observed in 
neurons (Lin et al., 2000; Maiese et al., 2000b) (Fig. 5). 
Experimental models suggest that activation of 
additional proteases rnay further degrade the 85 kDa 
PARP fragment (Taylor et al., 1997; Lin et al., 2000). 
In addition to the fragmentation of genomic DNA, 
induction of cysteine protease activity rnay also be 
responsible for the externalization of membrane PS 
residues. During cytokine mediated injury, the 
externalization of PS residues has previously been linked 
to the activity of caspase 1-like proteases through a 
mechanism that rnay involve the cleavage of membrane 
cytoskeletal proteins such as fodrin (Cryns et al., 1996; 
Kayalar et al., 1996). Current studies that employ 
visualization of PS externalization in individual cells 
have demonstrated that PS externalization is related to 
caspase 1-like activity (Maiese et al., 2000b; Vincent and 
Maiese, 2000). This externalization of membrane PS 
residues is independent of the loss of membrane integrity 
(Vincent et al., 1997; Maiese et al., 2000b; Maiese and 
Vincent, 2000b; Vincent and Maiese, 2000). Inhibition 
of caspase 1-like, but not caspase 3-like activity, 
following NO exposure can both prevent and reverse the 
Flg. 5. NO exposure results in PARP proteolysis in neurons. A 
representative western Mot is illustrated. Total protein extracts were 
prepared from either untreated control cultures or frorn extracts 
prepared 12 h following a 5 minute NO exposure. The NO donor 
ernployed was NOC-9 (300 pM). In both lanes, equal arnounts of 
neuronal protein extracts (25 pgllane) were separated by 7.5% SDS- 
PAGE and were then imrnunoblotted with polyclonal anti-PARP 
antibody. Detedon was by enhanced chernilurninescence. Lane 'C" 
(control) contained an extract frorn untreated rat hippocampal neuronal 
cultures. In lane 'NO" (nitric oxide), a decrease in the amount of 116 
kDa PARP occurred within 12 hr following NO exp6aure. The rnolecular 
weight marker is present on the ngM of the western blot. 
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externalization of PS residues. 
The cell cycle and tyrosine phosphatases: potential 
"up-stream" molecular targets against neuronal and 
vascular injury 
Cell cycle induction N, post-mitotic neurons and vascular 
ECs 
Although it is clear that the processes of PCD are 
intimately involved during neuronal and vascular injury, 
the molecular mechanisms that mediate cellular 
degeneration require further definition. It is conceivable 
that modulation of the cell cycle, especially in post 
mitotic neuronal cells, may represent one of the cellular 
pathways that is ultimately responsible for cellular 
injury. As one of the primary modulators of the cell 
cycle, the retinoblastoma gene product (pRb) is a 
llOkDa nuclear phosphoprotein that coordinates cellular 
pathways of growth and differentiation. 
The pRb gene was initially identified for its role in 
tumorigenesis (Knudsen, 1987), but subsequently was 
studied for its ability to suppress neoplastic growth 
(Yandell and Dryja, 1989). Hypophosphorylated pRb 
binds to and inactivates E2F transcription factors 
(Ludlow et al., 1990). Phosphorylation of pRb 
deregulates E2F activity and, depending on the cell type, 
can promote cell proliferation or tumorigenesis (Sherr, 
1994). Although pRb shares its ability with p53 to 
restrict G1 cell cycle progression, p53 acts upstream 
from pRb by inducing the p21 CDK inhibitor to prevent 
pRb phosphorylation (Hansen et al., 1986). Loss of pRb 
function can eliminate the ability of p53 to mediate G1 
arrest (Demers et al., 1994). Yet, in several cell systems, 
pRb can function independently of p53 to determine a 
cel17s fate (Hara et al., 1996; Serrano et al., 1996). For 
example, early stages of DNA damage in proliferating 
cells appear to be dependent on the phosphorylation state 
of pRb, but independent of p53 @ou et al., 1995). 
The pRb gene product leads a dual life not only as a 
"inhibitor of growth", but also as a "protector against 
death". Cells deficient in pRb function, such as pRb-1- 
mouse embryos and pRb-1- fibroblasts, are prone to 
death (Almasan et al., 1995). The massive PCD seen in 
these systems has been interpreted as a response to the 
loss of the pRb gene and the subsequent inactivation of 
mechanisms that usually safeguard against uncontrolled 
growth. Loss of functional pRb removes the checkpoint 
on the E2F transcription factors and allows cells to 
proceed past the G1 checkpoint into the S phase. This 
block on E2F transcription by pRb also can be removed 
during E2F over expression (Johnson et al., 1993). 
In the nervous system, animals that are homozygous 
for pRb deficiency develop until midgestation, then 
suffer from ectopic nervous system mitoses and succumb 
to extensive cell death (Lee et al., 1992). Prior to 
midgestation, pRb does not modulate the G1 checkpoint 
(Savatier et al., 1996). Thus, the pRb nullizygous animal 
supports the premise that pRb regulates neuronal cell 
cycle arrest. Yet, once neuronal cells have become 
committed and enter the process of differentiation, loss 
of pRb activity with subsequent cell cycle induction 
appears to result in degeneration and PCD in the nervous 
system. Other studies also support the premise that loss 
of cell cycle regulation by pRb can lead to neuronal 
PCD. For example, if pRb is de-activated in neuronal 
ectodermal cells that are destined for differentiation, loss 
of functional pRb triggers apoptosis (Slack et al., 1995). 
In addition, the expression of mitotic cyclins and their 
associated kinases have been reported during periods of 
neurodegenerative disease (Busser et al., 1998). During 
injury paradigms such as anoxia or NO exposure, 
phosphorylated pRb expression appears to promote PCD 
while the enhancement of hypophosphorylated pRb 
expression prevents the induction of PCD (Maiese and 
Gallant, 1997). 
As described, binding of hypophosphorylated pRb to 
E2F prevents the induction of cell transcription. As a 
result, deregulation of E2F can lead to PCD in some cell 
systems (Nevins, 1992). In addition, excessive 
production of E2F can overcome pRb7s ability to inhibit 
cell cycle progression (Lukas et al., 1996). Thus, E2F is 
a critica1 downstream target of pRb and offers a potential 
therapeutic target during NO induced neuronal injury 
and PCD induction. Recently, loss of E2F function and 
the subsequent ability to prevent cell transcription in 
post-mitotic neurons has been linked to the induction of 
PCD in both in vivo (MacManus et al., 1999) and in 
vitro systems (Shaw et al., 2000). 
El Wildtype 
SHP2 Mutant 
Concentration of NO donor (pM) 
Flg. 6. SHP2 mutant neurons have increased sensitivity to NO toxicity. 
lncreasing concentrations of a NO generator (NOC-9) for 5 minutes 
were applied to primary hippocampal wildtype and SHP2 mutant mouse 
neuronal cultures. The SHP2 mutant cultures have structurally intact 
SHP2 tyrosine phosphatase, but the SHP2 tyrosine phosphatase is 
functionally inactive. Neuronal survival was assessed 24 hours later 
using 0.4% trypan blue dye exclusion assay. In the absence of NO 
exposure, neuronal survival was approximateiy 88% (untreated control 
cultures). In each case, SHP2 mutant neurons are more sensitive to NO 
toxicity when compared to wildtype neurons. Data represents the mean 
and SE. 
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Tyrosine phosphatases offer cytoprotection against NO 
Src family members are tyrosine kinases that are 
maintained at the plasma membrane by an N-terminal 
myristyl group and are involved in severa1 cellular 
activities, such as cytoskeletal maintenance, cell 
division, and cell differentiation. SHP2 (SH-PTP2, 
PTPlD, Syp, PTP2C, and SH-PTP3) is a cytosolic 
protein tyrosine phosphatase that contains two Src 
homology 2 (SH2) domains (Vogel et al., 1993; Feng 
and Pawson, 1994), a protein tyrosine phosphatase 
domain, and a C-terminal hydrophilic domain with 
tyrosyl phosphorylation sites (Bennett et al., 1994). 
SHP2 has been linked to a variety of signaling pathways 
that involve receptor tyrosine kinases (Bennett et al., 
1996; Wright et al., 1997) and trophic factor signaling 
pathways (Milarski and Saltiel, 1994; Yamauchi et al., 
1995; Saxton et al., 1997). Of particular interest is the 
observation that SHP2 is expressed in the brain in areas 
such as the cortex, cerebellum, midbrain, and the 
hippocampus (Suzuki et al., 1995). 
Although the tyrosine phosphatase SHP2 is 
employed into tyrosine kinase signaling pathways as a 
regulator during cell growth and development, the role 
of SHP2 and its downstream signaling pathways during 
neuronal or vascular cell injury is not well understood. 
Recently, loss of function of SHP2 has been associated 
with enhanced neuronal injury and the induction of PCD 
(Miller et al., 2000; Zhang et al., 2000) (Fig. 6). 
Interestingly, cells that are deficient in SHP2 function 
are with overt evidence of anatomical or physiologic 
disability. Yet, during injury paradigms with anoxia or 
NO exposure, cells that are without intact SHP2 function 
suffer from early induction of genomic DNA 
degradation and membrane PS exposure (Miller et al., 
2000; Zhang et al., 2000). These observations suggest 
that SHP2 may be cytoprotective during neuronal or 
vascular degeneration. Given the knowledge that the 
cysteine proteases caspase 1 and caspase 3 directly 
modulate these independent pathways of PCD, it is 
conceivable that the ability of intact SHP2 function to 
offer cytoprotection during cell injury is linked to the 
regulation of cysteine protease activity. Recent work has 
established such a link and suggests that SHP2 directly 
prevents the induction of both caspase 1 and caspase 3- 
like activities during free radical injury (Miller et al., 
2000; Zhang et d., 2000). 
Future dlrections 
animal models and cell culture systems. The final 
cellular pathways that lead from the generation of NO to 
eventual cellular death are under continual investigation, 
but include intracellular calcium release (Maiese et al., 
1994b, 1999; Skarzynski et al., 2000), the modulation of 
protein kinase activity (Maiese et al., 1993b; Zhang, 
2000), enhanced neuronal endonuclease activity 
(Vincent and Maiese, 1999b; Vincent et al., 1999a), 
rapid induction of intracellular acidification (Ito et al., 
1997; Vincent et al., 1999b; Maiese et al., 2000b), 
activation of cysteine proteases (Brown and Borutaite, 
1999; Maiese and Vincent, 1999; Maiese et al., 2000b; 
Yabuki et al., 2000; Yamaguchi et al., 2000), cell cycle 
control (Maiese and Gallant, 1997; DiGregorio et al., 
2000), and tyrosine kinase regulation (Miller et al., 
2000; Zhang et d., 2000). 
Knowledge of the underlying pathways that 
modulate both neuronal and vascular injury serve to 
provide the foundation for the design of successful 
cytoprotective strategies. For example, by addressing the 
independent components of PCD which include genomic 
DNA degradation and membrane PS exposure, 
therapeutic regiments can then offer both novel and 
broad based cellular protection, such as demonstrated 
with the metabotropic glutamate system (Maiese et al., 
2000b; Vincent and Maiese, 2000), the upregulation of 
Bcl-2 (Fabisiak et al., 1997), or the agent nicotinamide 
(Lin et al., 2000). In this regard, therapy can provide 
both immediate and long-term cytoprotection. 
Immediate protection is afforded through the 
maintenance of intact genomic DNA. Long-term 
protection results through the inhibition of membrane PS 
residue exposure which can allow cells to be recognized 
by phagocytes for subsequent destruction. In addition, 
prevention of membrane PS exposure serves to maintain 
a normal anticoagulant state in ECs and prevent the 
development of atherosclerosis. 
Yet, it is clear that further investigation is required to 
isolate the downstream cellular and molecular 
mechanisms that control neuronal and vascular survival 
prior to the onset of PCD. Studies that focus on more 
conventional pathways as well as less accepted 
mechanisms, such as post-mitotic cell cycle regulation 
and cellular tyrosine phosphatase activity, can offer 
insight into the mechanisms that may actually reverse 
cellular injury once it has been initiated. Future 
investigations can then open new therapeutic 
foundations for the treatment of acute and chronic 
central nervous system disorders. 
Neurona1 and vascular injury may occur at severa1 
levels within a cell. Early studies supported the 
consensus that cellular injury is  closely tied to 
excitotoxicity (Rothman and Olney, 1986) and, in 
severa1 cellular environments, specific glutamate 
receptors play a significant role during both neuronal 
and vascular injury. Yet, alternate cellular pathways are 
increasingly being recognized as vital mechanisms that 
can regulate cellular injury. The free radical NO has 
clearly been linked to ischemic cellular injury in both 
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